Conflict of interest statement regarding COVID-19 tests evaluated by PHE
Updated 9 June 2021
© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/position-statement-regarding-covid-19-tests-evaluated-by-phe/conflict-of-interest-statement-regarding-covid-19-tests-evaluated-by-phe
Conflict of interest statement
Public Health England (PHE) has a comprehensive system for managing conflicts of interest. Companies provided free of charge to PHE the test kits required for its assessments of molecular and serological COVID-19 diagnostic products. They also provided on short-term loan any required proprietary equipment and software.
In line with its Conflict of Interest Policy, PHE works in co-operation with the pharmaceutical, biotechnology, vaccine, diagnostic, and other healthcare-related industries in order to facilitate the development of products and technologies beneficial to health. These relationships are managed on an arms-length, contractual and commercial basis, including the charging of fees under standard terms and conditions. In this context, PHE maintains active relationships with a broad range of companies in the UK and internationally.